SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-010501
Filing Date
2017-02-23
Accepted
2017-02-23 07:30:27
Documents
3
Period of Report
2017-02-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v460252_8k.htm 8-K 24049
2 EXHIBIT 99.1 v460252_ex99-1.htm EX-99.1 97812
3 GRAPHIC image_002.jpg GRAPHIC 4997
  Complete submission text file 0001144204-17-010501.txt   130226
Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011
Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35668 | Film No.: 17630741
SIC: 2834 Pharmaceutical Preparations